APAC
Medical billing outsourcing market to reach $45.8b by 2033
Its growth is attributed to the increasing complexity of healthcare billing processes.
APAC to record fastest growth in global burn care market
One key driver is the expansion of healthcare centres in countries, such as China and India.
Global heparin market to be valued at $15b by 2030
One key driver is the innovation in drug delivery systems and formulations.
What’s driving the global gastric cancer diagnostics market?
One key trend is the integration of molecular diagnostics such as next-generation sequencing.
Orthokeratology lens market to grow at 6.39% CAGR through 2028
Thanks to an increased demand for non-surgical vision correction alternatives.
Sleep apnea diagnostic systems market to reach $1.3b by 2033
The sector is driven by AI integration and a focus on home monitoring.
APAC local pharmaceutical firms challenge multinational dominance
This development is attributed to increased R&D investments and supportive government policies.
Neurological devices market to be valued at $20.9b by 2033
The sector’s growth is attributed to a rising prevalence of neurological disorders.
APAC to emerge as key player in the global AI oncology market
Its growth is fuelled by rapid technological advancements and increased healthcare investments.
Global audiological devices market to rise at 8.9% CAGR through 2028
Hearing aids and cochlear implants serve as primary devices in the sector.
Bariatric surgical devices market to grow by $589m by 2028
It is fueled by rising obesity rates and a shift toward minimally invasive procedures.
Wireless brain sensors market to grow 9% CAGR by 2030
However, high costs and data security concerns may impede its expansion.
Head and neck cancer diagnostics market to grow by $6.3b by 2028
The sector is experiencing an upward trend in immunotherapy use.
AR technology in healthcare to rise 36% CAGR through 2033
Its use in surgeries is linked to reduced complications and improved patient outcomes.
Heart closure devices market to rise at 7% CAGR through 2030
One key driver is the rising incidence of congenital heart defects.
Cardiopulmonary stress testing systems market to grow by $2.18b by 2028
Thanks to an increase in heart speciality centres and a rise in heart and lung diseases.